GSK Augmentin Response To Zithromax: One-Day Dosing Offset By Vomiting
Executive Summary
Increased vomiting associated with one-day Zithromax will be a focal point of GlaxoSmithKline's promotional response to the improved dosing for Pfizer's acute otitis media product
You may also be interested in...
GSK Augmentin ES Conversion Rate Reaches 31%; XR Filing Imminent
GlaxoSmithKline is converting about one-third of Augmentin suspension Rxs to the ES-600 formulation, GSK Chief Operating Officer Bob Ingram told securities analysts Feb. 14
GSK Augmentin ES Conversion Rate Reaches 31%; XR Filing Imminent
GlaxoSmithKline is converting about one-third of Augmentin suspension Rxs to the ES-600 formulation, GSK Chief Operating Officer Bob Ingram told securities analysts Feb. 14
Pfizer Zithromax Short Regimen Promotions Will Include Patient Brochure
Pfizer's promotions for one- and three-day Zithromax regimens will include an educational campaign aimed at patients, parents and physicians on treating acute otitis media